These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26100653)

  • 41. Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells.
    Huang Y; Sadée W
    Cancer Lett; 2006 Aug; 239(2):168-82. PubMed ID: 16169662
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of membrane transporters in ovarian cancer chemoresistance and prognosis.
    Cerovska E; Elsnerova K; Vaclavikova R; Soucek P
    Expert Opin Drug Metab Toxicol; 2017 Jul; 13(7):741-753. PubMed ID: 28511565
    [TBL] [Abstract][Full Text] [Related]  

  • 43.  Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma.
    Sribenja S; Natthasirikul N; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Jearanaikoon P; Wongkham S
    Ann Hepatol; 2016; 15(4):577-85. PubMed ID: 27236157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of inhibitors of ATP-binding cassette drug transporters: present status and challenges.
    Shukla S; Wu CP; Ambudkar SV
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):205-23. PubMed ID: 18248313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence of ABC transporters in fresh tumor cells from patients with ovarian cancer.
    Sargent JM; Coley HM; Williamson C; Taylor C
    Int J Clin Pharmacol Ther; 1998 Feb; 36(2):64-6. PubMed ID: 9520144
    [No Abstract]   [Full Text] [Related]  

  • 46. ABCG2: the key to chemoresistance in cancer stem cells?
    An Y; Ongkeko WM
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1529-42. PubMed ID: 19708828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells.
    Borowski E; Bontemps-Gracz MM; Piwkowska A
    Acta Biochim Pol; 2005; 52(3):609-27. PubMed ID: 16175236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ABC transporter gene expression in benign and malignant ovarian tissue.
    Auner V; Sehouli J; Oskay-Oezcelik G; Horvat R; Speiser P; Zeillinger R
    Gynecol Oncol; 2010 May; 117(2):198-201. PubMed ID: 19922990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer.
    Modok S; Mellor HR; Callaghan R
    Curr Opin Pharmacol; 2006 Aug; 6(4):350-4. PubMed ID: 16690355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance.
    Revalde JL; Li Y; Hawkins BC; Rosengren RJ; Paxton JW
    Biochem Pharmacol; 2015 Feb; 93(3):305-17. PubMed ID: 25543853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line.
    Januchowski R; Zawierucha P; Ruciński M; Andrzejewska M; Wojtowicz K; Nowicki M; Zabel M
    Biomed Pharmacother; 2014 May; 68(4):447-53. PubMed ID: 24814220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Structural basis for the mechanism of ABC transporters.
    Beis K
    Biochem Soc Trans; 2015 Oct; 43(5):889-93. PubMed ID: 26517899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?
    Yu M; Ocana A; Tannock IF
    Cancer Metastasis Rev; 2013 Jun; 32(1-2):211-27. PubMed ID: 23093326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein.
    Erić S; Kalinić M; Ilić K; Zloh M
    SAR QSAR Environ Res; 2014; 25(12):939-66. PubMed ID: 25435255
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of ATP-binding cassette transporters in cancer initiation and progression.
    Nobili S; Lapucci A; Landini I; Coronnello M; Roviello G; Mini E
    Semin Cancer Biol; 2020 Feb; 60():72-95. PubMed ID: 31412294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
    Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T
    J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suppression of c-Myc is involved in multi-walled carbon nanotubes' down-regulation of ATP-binding cassette transporters in human colon adenocarcinoma cells.
    Wang Z; Xu Y; Meng X; Watari F; Liu H; Chen X
    Toxicol Appl Pharmacol; 2015 Jan; 282(1):42-51. PubMed ID: 25461681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Yeast ABC transporters in lipid trafficking.
    Prasad R; Khandelwal NK; Banerjee A
    Fungal Genet Biol; 2016 Aug; 93():25-34. PubMed ID: 27259587
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.
    Bugde P; Biswas R; Merien F; Lu J; Liu DX; Chen M; Zhou S; Li Y
    Expert Opin Ther Targets; 2017 May; 21(5):511-530. PubMed ID: 28335655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.